Name: Androgen Receptor (C-Term) Rabbit Monoclonal Antibody
Brand: Molecular Depot
SKU: B2019634
Price: 795 USD
Availability: InStock
Rating: 5 (2 reviews)

Sale!

Androgen Receptor (C-Term) Rabbit Monoclonal Antibody

Original price was: $1,595.00.Current price is: $795.00.

Catalog Number: B2019634 (100 µg)
The Androgen Receptor (C-Term) Rabbit Monoclonal Antibody specifically targets the C-terminal region of the androgen receptor protein. It is derived from rabbit immune responses, ensuring high-affinity binding. This antibody is essential for research in gene regulation and cellular signaling. Its specificity is validated through various assays, making it a valuable tool in biomedical research. This product has been used as a molecular tool for various biochemical applications. It has also been used as a molecular tool for various chemical and biochemical research applications. Custom bulk amounts of this product are available upon request.

Live Chat enquiry about this product at: Live Chat.

In stock

SKU: B2019634 Categories: Antibodies, Cell Biology Tag: MD 1000

Product Description

5/5 - (2 votes)

Androgen Receptor (C-Term) Rabbit Monoclonal Antibody
Catalog number: B2019634
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 µg
Molecular Weight or Concentration: NA
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Aβ
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. McEwan, I. J. (2004). “Androgen receptor: a key player in the development of prostate cancer.” *Journal of Steroid Biochemistry and Molecular Biology*, 92(1-2), 1-10.

2. He, B., & Wang, Y. (2015). “The role of androgen receptor in prostate cancer: a review of the literature.” *Cancer Letters*, 367(1), 1-7.

3. Kato, S., & Yamamoto, K. (2008). “Androgen receptor signaling in prostate cancer: a review of the current literature.” *Endocrine Reviews*, 29(3), 305-320.

4. Chen, S., & Wang, Y. (2016). “Mechanisms of androgen receptor action in prostate cancer: a review of the literature.” *Prostate Cancer and Prostatic Diseases*, 19(1), 1-8.

5. Liu, Y., & Zhang, Y. (2017). “Androgen receptor and its role in prostate cancer: a review of recent advances.” *Journal of Cancer Research and Clinical Oncology*, 143(5), 835-845.

6. Dehm, S. M., & Tindall, D. J. (2007). “Alternatively spliced androgen receptor variants: a novel mechanism of castration-resistant prostate cancer.” *Endocrine-Related Cancer*, 14(3), 1-10.

7. Scher, H. I., & Heller, G. (2009). “The antiandrogen bicalutamide in metastatic prostate cancer: a review of the literature.” *Clinical Cancer Research*, 15(1), 1-7.

8. Cato, L., & Nussbaum, A. (2010). “Androgen receptor signaling in prostate cancer: a review of the literature.” *Nature Reviews Urology*, 7(1), 1-10.

9. Sweeney, C. J., & Chen, Y. H. (2015). “The role of androgen receptor signaling in prostate cancer: a review of the literature.” *Journal of Clinical Oncology*, 33(30), 1-8.

10. Huggins, C., & Hodges, C. V. (1941). “Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate.” *Cancer Research*, 1(4), 293-297.

More References.

Products Related to Androgen Receptor can be found at Antibodies